Posttransplant Xospata Does Not Worsen Quality of Life in AML

While posttransplant Xospata did not worsen quality of life in patients with acute myeloid leukemia, it is essential that patients tell their providers about any side effects that they experience, an expert said.

Related Keywords

Betty Hamilton ,Marrow Transplant Clinical Trials Network ,Cellular Therapy Meetings ,Functional Assessment ,Cancer Therapy Bone Marrow Transplant ,News ,Acute Myeloid Leukemia ,Leukemia ,Cure Tv ,Posttransplant Xospata ,